Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 11/20 | 0.39 |
| ▸ | CTSK | P43235 | 10/20 | 0.39 |
| ▸ | CTSL | P07711 | 4/20 | 0.38 |
| ▸ | CTSB | P07858 | 2/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | FNTA | P49354 | 2/20 | 0.37 |
| ▸ | FNTB | P49356 | 2/20 | 0.37 |
| ▸ | TNF | P01375 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | TTK | P33981 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22410268 | 0.89 | IDO1 (0.38) | CTSSCTSKCTSLHDAC8IDO1 | |
| SCHEMBL22410271 | 0.89 | IDO1 (0.38) | CTSSCTSKCTSLHDAC8IDO1 | |
| SCHEMBL22126009 | 0.88 | AAK1 (0.40) | CTSSCTSKCTSLCTSBHDAC8 | |
| SCHEMBL29894827 | 0.88 | AAK1 (0.40) | CTSSCTSKCTSLCTSBHDAC8 | |
| SCHEMBL28607155 | 0.86 | SCN9A (0.44) | CTSSCTSKCTSLCTSBHDAC8 | |
| SCHEMBL22144051 | 0.83 | NPC1 (0.38) | CTSSCTSKCTSLCTSBFNTA | |
| SCHEMBL22143835 | 0.83 | FNTA (0.39) | FNTAFNTBTNFIDO1 | |
| SCHEMBL28609015 | 0.79 | HDAC8 (0.53) | CTSSCTSKCTSLCTSBHDAC8 | |
| SCHEMBL28605021 | 0.78 | MEN1 (0.48) | CTSSCTSKCTSLCTSBIDO1 | |
| SCHEMBL22410400 | 0.77 | EGFR (0.37) | HDAC8IDO1CYP3A4SCN9ASCN10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11377425-B1 | Small molecule modulators of IL-17 | LEO PHARMA A/S (DK) | 2022-07-05 | — | — | US | disclosed |
| CN-113164448-A | Amino acid anilines as small molecule modulators of IL-17 | 利奥制药有限公司 | 2021-07-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377425-B1 | Small molecule modulators of IL-17 | IL17A, IL15, IL2 | EGLN2 771/4885CTSS 757/4885CTSK 441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.